Animal-based research into the action of GHRP-6, a prominent research compound, have extended along a wide range of research avenues, including studies in weight regulation and muscle cell proliferation, energy homeostasis and stamina, metabolism, libido, memory, focus, sleep cycles, and tissue repair processes.

In addition, research indicates it may act to participate in repair processes related to cardiac damage and liver fibrosis. A decrease in blood sugar levels and increased appetite are theorized to have additional impacts. Read on for a more thorough summary of existing research surrounding this peptide.

GHRP-6 Peptide: What is it?

A hexapeptide with six amino acids, GHRP6 stands for Growth Hormone Releasing Peptide 6. To stimulate the organism’s natural synthesis of growth hormone (GH), the GHRP-6 peptide is speculated to block the action of somatostatin, suppressing GH release. According to the study, the brain is responsible for the process, but the pituitary gland makes it possible once engaged.

GHRP-6 Peptide: Mechanism of Action

Synthetic gonadotropin-releasing peptides (GHRPs) are believed to stimulate the pituitary gland to secrete endogenous gonadotropins.

Research indicates that the pituitary gland stimulates and enhances growth hormone synthesis, enabling the organism to produce GHRP-6. The impacts on the mice’s hormone levels have also been studied.

Investigations purport that GHRP-6 may aid in transmitting instructions from the brain to the internal systems within the organism to maintain an active release of GH. In another way, research has indicated that this peptide hormone may allow the organism to reap the properties of continuous GH in mice.

GHRP-6 has been hypothesized to activate the pituitary glands, also called Somatotrophs, to facilitate the production and distribution of growth hormone.

GHRP-6 Peptide Potential

Based on its alleged function in promoting Growth Hormone production, research indicates that GHRP-6 may have many potential downstream impacts within the animal. The following are some of the most speculated properties of GHRP-6 as suggested in animal studies:
  • It may increase vitality
  • It may strengthen and increase endurance
  • It may enhance thermogenesis
  • It may improve erection consistency
  • It may promote hair follicle development
  • It may reduce wrinkle depth
  • It may strengthen memory-recall in certain learning processes
  • It may boost defenses against illness
  • It may act to regulate the sleep cycle
  • It may mitigate the secretion of stress hormones
  • It may act to expedite tissue repair

GHRP-6 Peptide and Weight

According to new scientific studies, the appetite-stimulating hormone ghrelin seems improved in mice by GHRP-6. When no food is in the stomach, the organism releases the hormone ghrelin. Moreover, it has been theorized to facilitate quicker healing and restoration of injured tendons in mice. Its primary claim to fame, however, is the fat-burning results it may produce.

Animal studies have reported that the potential to burn fat simultaneously and build muscle might be enhanced when the liver secretes the IGF-1 hormone in response to GHRP-6 stimulation of Growth Hormone production. Based on results from animal studies, GHRP-6 has recently been speculated to act in lipolytic fashion, reducing stores of fat cells within the organism.

GHRP-6 Peptide and Muscle Cells

The New England Journal of Medicine reported that mice given growth hormone for six months appeared to have increased their lean mass by 8.8% and decreased their fat mass by 14.0%. While most fat loss was hypothesized to have occurred in the abdominal region, bone density was speculated to have risen 1.4 percent, and the skin appeared to have thickened.

GHRP-6 Peptide and Injuries

A study published in Clinical Science indicated that presenting GHRP-6 to pigs regularly may have significantly reduced interior heart attack damage, providing speculation about GHRP-6’s capabilities.

Researchers hypothesized that GHRP-6 may have restorative potential to speed up the healing process for both injuries and overall tissue recovery in mice.

GHRP-6 Peptide and Fibrosis

According to the current study, growth hormone-releasing peptide 6 (GHRP-6) seems to potentially decrease fibrotic induration in the liver.

After incisions measuring 6 mm were made on the backs of Wistar rats, they were given GHRP-6 twice daily for five days. Data from the rat study suggests the idea that GHRP-6’s pharmacodynamics may include reducing the production of fibrotic cytokines and immunoinflammatory mediators. This points to GHRP-6 having a potential anti-inflammatory impact.

Scientists interested in high-quality, affordable GHRP-6 for sale are encouraged to navigate the Core Peptides website. Please note that none of the substances mentioned in this article have been approved for human or animal consumption.

References:

[i] Berlanga-Acosta, Jorge, Gerardo Guillen Nieto, Ernesto Lopez-Mola, and Luis Herrera-Martinez. “Growth Hormone Releasing Peptide-6 (GHRP-6) and Other Related Secretagogue Synthetic Peptides: A Mine of Medical Potentialities for Unmet Medical Needs.” Integrative Molecular Medicine 3, no. 2 (2016): 616–623. doi:10.15761/imm.1000213.

[ii] Berlanga-Acosta, Jorge, Angel Abreu-Cruz, Diana García-del Barco Herrera, Yssel Mendoza-Marí, Arielis Rodríguez-Ulloa, Ariana García-Ojalvo, Viviana Falcón-Cama, Francisco Hernández-Bernal, Qu Beichen, and Gerardo Guillén-Nieto. “Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.” Clinical Medicine Insights: Cardiology 11 (January 2017): 117954681769455. doi:10.1177/1179546817694558. [iii] Mendoza Marí, Yssel, Maday Fernández Mayola, Ana Aguilera Barreto, Ariana García Ojalvo, Yilian Bermúdez Alvarez, Ana Janet Mir Benítez, and Jorge Berlanga Acosta. “Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds.” Plastic Surgery International 2016 (April 2016): 1–11. doi:10.1155/2016/4361702. [iv] Pombo M, Leal-Cerro A, Barreiro J, Peñalva A, Peino R, Mallo F, Dieguez C, Casanueva FF. Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency. J Pediatr Endocrinol Metab. 1996 Jun;9 Suppl 3:333-8. PMID: 8887178. [v] Popovic V, Micic D, Damjanovic S, Djurovic M, Simic M, Gligorovic M, Dieguez C, Casanueva FF. Evaluation of pituitary GH reserve with GHRP-6. J Pediatr Endocrinol Metab. 1996 Jun;9 Suppl 3:289-98. PMID: 8887173.

This article appears in Jul 17-30, 2024.